SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-275110
Filing Date
2021-09-16
Accepted
2021-09-16 16:05:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d232278dsc13da.htm SC 13D/A 27824
  Complete submission text file 0001193125-21-275110.txt   29211
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89959 | Film No.: 211258011
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Wagner Paul A. (Filed by) CIK: 0001612842 (see all company filings)

Type: SC 13D/A